COVID-19 - Funding Opportunities

COVID-19 - Funding Opportunities

In the following, we summarise funding opportunities concerning the COVID-19 pandemic.

BioM supports biopharmaceutical companies in implementing their ideas and projects. Therefore, we are happy to help you find the right funding programmes and contact persons. Please contact us at

Bavarian Funding Possibilities

Call for funding Bavarian Therapy Strategy to Combat the COVID-19 Pandemic (Call for funding "BayTherapie2020"), (Deadline: January 31, 2021).

National Funding Information

Bundesministerium für Bildung und Forschung (BMBF)
Coronavirus: Advice and administration

Guideline to support research and development of urgently needed therapeutics against SARS-CoV-2. (Deadline: February 17, 2021)

Special programme to accelerate research and development of urgently needed vaccines against SARS-CoV-2

4th Call Computational Life Sciences - AI Methods for Infection Research

Nationale Kontaktstelle Lebenswissenschaften
Overview of COVID-19 funding programs

EU-Funding Opportunities

EU Commission - Horizon 2020

COVID-X: Defeating COVID-19 with Data Solutions (Deadline: January 27, 2021)

European Research Area (ERA) corona platform

The Research Executive Agency (REA) provides information on the effects on application submission, review and project processing in Horizon 2020 . Information is available on MSC-measures.

HERA Incubator
European bio-defence preparedness plan against COVID-19 variants

Other Funding Opportunities

Broad range of initiatives to respond to COVID-19 Pandemic

Blumorpho und EuroScan
Together against the Covid-19 pandemic

Science|Business Database: Coronavirus Funding Opportunities

JEDI (Joint European Disruptive Initiative)
Billion Molecules against COVID-19 Grand Challenge

Creative Destruction Lab
CDL Recovery

Dr. Petra Burgstaller
Dr. Petra Burgstaller

Head of inQlab

Christina Enke-Stolle
Christina Enke-Stolle

Head of inQlab